Jordan Dubow

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 239 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

Robert C. Griggs, J. Philip Miller, Cheryl R. Greenberg et al. · Neurology · 2016 · 176 citations · Full text

Medicine, Pharmacotherapy, Musculoskeletal Rehabilitation +13

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Andrew McGarry, Shane Rosanbalm, Mika Leinonen et al. · The Lancet Neurology · 2023 · 129 citations

Life Sciences, Neurology, Neuroscience +9

Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients

John T. Slevin, Hubert H. Fernandez, Cindy Zadikoff et al. · Journal of Parkinson s Disease · 2015 · 103 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials

Anthony E. Lang, Ramon L. Rodriguez, James T. Boyd et al. · Movement Disorders · 2015 · 101 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10